Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

India · Delayed Price · Currency is INR

133.41

+3.39 (2.61%)

At close: Jul 14, 2026

60.73% (1Y)

Market Cap	9.71B
Revenue (ttm)	1.04B +135.8%
Net Income	244.61M +80.9%
EPS	3.92 +78.0%
Shares Out	72.79M
PE Ratio	34.03
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	705,439
Open	131.90
Previous Close	130.02
Day's Range	123.52 - 136.52
52-Week Range	69.18 - 133.41
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 15, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopi... [Read more]

Industry Specialty Outpatient Facilities, Not Elsewhere Classified

Founded 2009

Country India

Stock Exchange National Stock Exchange of India

Ticker Symbol GAUDIUMIVF

Full Company Profile

Financial Performance

In fiscal year 2026, NSE:GAUDIUMIVF's revenue was 1.04 billion, an increase of 47.56% compared to the previous year's 707.24 million. Earnings were 244.61 million, an increase of 27.88%.

Financial Statements